Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Allen and Hanburys was a pioneering British pharmaceutical company founded in 1715, originally operating as a pharmacy in London. The company gained international recognition for its contributions to respiratory medicine, most notably the development of the bronchodilator Ventolin (salbutamol) and various inhaled corticosteroids. In 1958, the firm was acquired by Glaxo Laboratories, forming a key pillar of what would eventually become GSK. Throughout the 20th century, it operated as a specialist division within the Glaxo group, focusing on the UK market and respiratory health. While no longer an independent entity, its legacy continues through GSK's extensive respiratory portfolio and its historic manufacturing site in Ware, England.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allen and Hanburys.